Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Oura hits pause on its IPO amid shaky market conditions. Smart ring and health tracking company Oura has delayed its planned Nasdaq IPO, citing "uncertainty in the IPO market" — even as it reports strong business performance. The company had aimed to raise $2.2 billion, but says it has the "luxury of choosing its moment" to go public.
Oura hits pause on its IPO amid shaky market conditions
Smart ring maker Oura has postponed its planned Nasdaq IPO, citing "uncertainty in the IPO market" — despite reporting robust business fundamentals. The company, which tracks over 50 health metrics via its wearable ring, says it remains profitable and growing, with consumer response to its newly launched Oura Ring 5 described as "exceptionally strong."
Oura had set its sights on raising $2.2 billion by offering 50 million shares priced between $40 and $44 each. The company filed an S-1 with the SEC and estimated net proceeds of roughly $532.6 million from its portion of the offering. CEO Tom Hale struck a patient tone, saying the company has "the luxury of choosing our moment."
By the Numbers
Why it matters: Oura's delay signals a broader cooling in the digital health IPO market — a trend that could affect investor appetite and funding timelines for other health tech companies eyeing public listings.
